Which Endpoints to Use in Clinical Trials in Venous Thromboembolism?

Publisher： Karger

E-ISSN： 1424-8840|28|3|108-108

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.28, Iss.3, 2004-11, pp. : 108-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Surrogate Endpoints for the Assessment of Efficacy in Venous Thromboembolism Treatment Trials

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 127-130

Karger

Access to resources Recommend Favorite

Symptomatic Endpoints for Venous Thromboembolism Treatment

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 120-126

Karger

Access to resources Recommend Favorite

Clinical burden of venous thromboembolism

By Ruppert Andras   Lees Michael   Steinle Thomas  

Current Medical Research and Opinion, Vol. 26, Iss. 10, 2010-10 ,pp. : 2465-2473

Informa Healthcare

Access to resources Recommend Favorite

Index clinical manifestation of venous thromboembolism predicts early recurrence type and frequency: a meta‐analysis of randomized controlled trials

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 6, 2015-06 ,pp. : 1043-1052

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cancer and Venous Thromboembolism. Clinical Implications of Strong Association

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 35, Iss. 1-2, 2006-06 ,pp. : 111-115

Karger

Access to resources Recommend Favorite